allergic to glp 1 Delayed type hypersensitivity injection site reaction and tolerance induction liraglutide for the treatment of obesity Hypersensitivity to glucagon‐like peptide‐1 receptor
Description
In a murine model of OA induced by sodium monoiodoacetate (MIA), intra-articular administration of liraglutide effectively mitigated OA-associated pain [45]
Obesity as a Public Health Crisis and Contemporary Therapies Between 2021 and 2023, the prevalence of obesity, defined as a body-mass index (BMI, weight in kilograms divided by square of height in meters) 30, in adults in the United States increased to 40.3%, with no significant differences between men and women [6]
Akram U, Rehman OU, Fatima E, et al
When you can only consume 1,000 to 1,200 calories daily, every bite carries weight that normal eating never demanded
FerhatbegoviLMriDMaci-DankoviA
Several physiological and clinical factors can influence tirzepatide pharmacokinetics, potentially affecting drug levels and therapeutic response
